| # | Title | Journal | Year | Citations |
|---|
| 1 | Epidermal growth factor-related peptides and their receptors in human malignancies | Critical Reviews in Oncology/Hematology | 1995 | 2,457 |
| 2 | The cellular and molecular basis of hyperthermia | Critical Reviews in Oncology/Hematology | 2002 | 1,419 |
| 3 | The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer | Critical Reviews in Oncology/Hematology | 2013 | 1,106 |
| 4 | Use of comprehensive geriatric assessment in older cancer patients: | Critical Reviews in Oncology/Hematology | 2005 | 1,002 |
| 5 | Nickel essentiality, toxicity, and carcinogenicity | Critical Reviews in Oncology/Hematology | 2002 | 884 |
| 6 | The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophages | Critical Reviews in Oncology/Hematology | 2008 | 866 |
| 7 | Employment and work-related issues in cancer survivors | Critical Reviews in Oncology/Hematology | 2011 | 655 |
| 8 | Stem cell origin of cancer and differentiation therapy | Critical Reviews in Oncology/Hematology | 2004 | 581 |
| 9 | Vanadium in cancer treatment | Critical Reviews in Oncology/Hematology | 2002 | 532 |
| 10 | Mechanisms of resistance to cisplatin and carboplatin | Critical Reviews in Oncology/Hematology | 2007 | 525 |
| 11 | Vascular endothelial growth factor (VEGF) signaling in tumor progression | Critical Reviews in Oncology/Hematology | 2007 | 515 |
| 12 | Cathepsin D—Many functions of one aspartic protease | Critical Reviews in Oncology/Hematology | 2008 | 514 |
| 13 | Surgical risk factors, morbidity, and mortality in elderly patients | Critical Reviews in Oncology/Hematology | 2008 | 498 |
| 14 | Radiation-associated cardiovascular disease | Critical Reviews in Oncology/Hematology | 2003 | 461 |
| 15 | TIMPs as multifacial proteins | Critical Reviews in Oncology/Hematology | 2004 | 460 |
| 16 | Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help | Critical Reviews in Oncology/Hematology | 2008 | 447 |
| 17 | Chemotherapy-induced peripheral neurotoxicity (CIPN): An update | Critical Reviews in Oncology/Hematology | 2012 | 441 |
| 18 | Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy | Critical Reviews in Oncology/Hematology | 2001 | 428 |
| 19 | Regulation of angiogenesis by hypoxia-inducible factor 1 | Critical Reviews in Oncology/Hematology | 2006 | 423 |
| 20 | Circulating microRNAs: Association with disease and potential use as biomarkers | Critical Reviews in Oncology/Hematology | 2011 | 421 |
| 21 | Use of ?-asparaginase in childhood ALL | Critical Reviews in Oncology/Hematology | 1998 | 399 |
| 22 | Comprehensive geriatric assessment can predict complications in elderly patients after elective surgery for colorectal cancer: A prospective observational cohort study | Critical Reviews in Oncology/Hematology | 2010 | 389 |
| 23 | Major and minor salivary gland tumors | Critical Reviews in Oncology/Hematology | 2010 | 387 |
| 24 | Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation | Critical Reviews in Oncology/Hematology | 2005 | 381 |
| 25 | The Wnt signaling pathway in cancer | Critical Reviews in Oncology/Hematology | 2016 | 377 |
| 26 | Nutritional support of the cancer patient: issues and dilemmas | Critical Reviews in Oncology/Hematology | 2000 | 363 |
| 27 | Immunosuppressive agents in solid organ transplantation: Mechanisms of action and therapeutic efficacy | Critical Reviews in Oncology/Hematology | 2005 | 363 |
| 28 | Multicellular resistance: a paradigm for clinical resistance? | Critical Reviews in Oncology/Hematology | 2000 | 359 |
| 29 | Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): A review of the literature | Critical Reviews in Oncology/Hematology | 2007 | 358 |
| 30 | Gastric cancer | Critical Reviews in Oncology/Hematology | 2009 | 347 |
| 31 | Exploring miRNA based approaches in cancer diagnostics and therapeutics | Critical Reviews in Oncology/Hematology | 2016 | 334 |
| 32 | Prognostic impact of increasing age and co-morbidity in cancer patients: A population-based approach | Critical Reviews in Oncology/Hematology | 2005 | 333 |
| 33 | Associations of social networks with cancer mortality: A meta-analysis | Critical Reviews in Oncology/Hematology | 2010 | 330 |
| 34 | Diffuse large B-cell lymphoma | Critical Reviews in Oncology/Hematology | 2013 | 323 |
| 35 | Particular aspects of platinum compounds used at present in cancer treatment | Critical Reviews in Oncology/Hematology | 2002 | 322 |
| 36 | PD-L1 expression in cancer patients receiving anti PD-1/PD-L1 antibodies: A systematic review and meta-analysis | Critical Reviews in Oncology/Hematology | 2016 | 316 |
| 37 | The possible role of matrix metalloproteinase (MMP)-2 and MMP-9 in cancer, e.g. acute leukemia | Critical Reviews in Oncology/Hematology | 2004 | 308 |
| 38 | Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion | Critical Reviews in Oncology/Hematology | 2004 | 307 |
| 39 | Recognition and processing of cisplatin- and oxaliplatin-DNA adducts | Critical Reviews in Oncology/Hematology | 2005 | 306 |
| 40 | Meningioma | Critical Reviews in Oncology/Hematology | 2008 | 301 |
| 41 | Retinoids and their receptors in cancer development and chemoprevention | Critical Reviews in Oncology/Hematology | 2002 | 293 |
| 42 | Copper and carcinogenesis | Critical Reviews in Oncology/Hematology | 2002 | 293 |
| 43 | A potential role of macrophage activation in the treatment of cancer | Critical Reviews in Oncology/Hematology | 2002 | 291 |
| 44 | Pharmacological and clinical evaluation of l-asparaginase in the treatment of leukemia | Critical Reviews in Oncology/Hematology | 2007 | 286 |
| 45 | Colon cancer | Critical Reviews in Oncology/Hematology | 2010 | 285 |
| 46 | On the dual roles and polarized phenotypes of neutrophils in tumor development and progression | Critical Reviews in Oncology/Hematology | 2012 | 280 |
| 47 | Pathological prognostic factors in breast cancer | Critical Reviews in Oncology/Hematology | 1999 | 278 |
| 48 | Platelet microparticles: a wide-angle perspective | Critical Reviews in Oncology/Hematology | 1999 | 275 |
| 49 | E-cadherin: Its dysregulation in carcinogenesis and clinical implications | Critical Reviews in Oncology/Hematology | 2018 | 274 |
| 50 | Epstein–Barr virus-associated malignancies: epidemiologic patterns and etiologic implications | Critical Reviews in Oncology/Hematology | 2000 | 273 |
